← Scroll for more →
Abbott Laboratories (ABT)
Pharmaceutical Preparations
Latest Price
$98.83
TTM P/E
27.68
Normalized P/E
21.96
Div Yield
2.47%
Book Value
29.89
P/B Ratio
3.31
Valuation metrics
adjust assumptions →EPS: $3.72
Book value / share: $29.82
Formula: √(22.5 × EPS × BVPS)
Graham Number
$49.96
49% downside
Norm. op. income: $6.8B (median of 7yr)
Tax rate: 14%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$31.29
68% downside
Base FCF: $7.4B (median of recent 5yr)
Growth: 21%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$228.56
+131% upside
EPS: $3.72
Target P/E: 22×
Formula: EPS × P/E
P/E Fair Value
$81.84
17% downside
Institutional Ownership
82.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 152.56M | $13.84B | 8.76% | +6.77M | 2026-06-30 |
| Vanguard Capital Management LLC | 113.75M | $10.32B | 6.53% | +801.1K | 2026-06-30 |
| State Street Corp | 80.93M | $7.34B | 4.64% | +1.35M | 2026-06-30 |
| Charles Schwab Investment Management Inc | 59.67M | $5.41B | 3.42% | +14.17M | 2026-06-30 |
| Sixth Street Partners Management Company, L.P. | 59.67M | $5.41B | 3.42% | -- | 2026-06-30 |
| Vanguard Portfolio Management LLC | 49.02M | $4.45B | 2.81% | +1.07M | 2026-06-30 |
| Geode Capital Management, LLC | 39.22M | $3.54B | 2.25% | +70.5K | 2026-06-30 |
| Capital Research Global Investors | 36.91M | $3.35B | 2.12% | -12.87M | 2026-06-30 |
| Capital International Investors | 34.65M | $3.15B | 1.99% | -2.84M | 2026-06-30 |
| Morgan Stanley | 26.61M | $2.41B | 1.53% | -3.49M | 2026-06-30 |